Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Completed 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 492 Pancreatic Neoplasms 387 Carcinoma, Hepatocellular 261 Colonic Neoplasms 214 Stomach Neoplasms 200 Rectal Neoplasms 190 Esophageal Neoplasms 157 Neoplasms 139 Carcinoma, Non-Small-Cell Lung 133 Liver Neoplasms 129 Neoplasm Metastasis 124 Breast Neoplasms 102 Cholangiocarcinoma 94 Melanoma 85 Ovarian Neoplasms 79 Lung Neoplasms 72 Squamous Cell Carcinoma of Head and Neck 57 Carcinoma, Renal Cell 57 Gastrointestinal Neoplasms 55 Sarcoma 46 Biliary Tract Neoplasms 39 Prostatic Neoplasms 36 Head and Neck Neoplasms 36 Esophageal Squamous Cell Carcinoma 36 Adenocarcinoma Of Esophagus 36 Urinary Bladder Neoplasms 33 Adenocarcinoma 33 Uterine Cervical Neoplasms 31 Triple Negative Breast Neoplasms 31 Gastrointestinal Stromal Tumors 31

Interventions

Lapatinib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × GastroEsophageal Cancer × Gastrointestinal × Clear all

NCT01145404 2014-07-02

GastroLap

National Center for Tumor Diseases, Heidelberg

Phase 2 Terminated

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡